|
|
|
Corporate Profile: iQur
| Summary: |
iQur is focused on the research and development of vaccines using an HBV core VLP technology.
|
| Address (HQ): |
London Bioscience & Innovation Centre
2 Royal College Street
London, NW1 0NH
United Kingdom |
| Phone
#'s (HQ): |
| Main |
+44 20 7691 1122 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
+44 20 7681 9129 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
info@iqur.com |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
